236 related articles for article (PubMed ID: 15546799)
1. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies.
Meroni PL; Raschi E; Testoni C; Parisio A; Borghi MO
Autoimmun Rev; 2004 Nov; 3(7-8):510-5. PubMed ID: 15546799
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell activation by antiphospholipid antibodies.
Meroni PL; Raschi E; Testoni C; Borghi MO
Clin Immunol; 2004 Aug; 112(2):169-74. PubMed ID: 15240160
[TBL] [Abstract][Full Text] [Related]
3. Endothelium activation in the anti-phospholipid syndrome.
Raschi E; Testoni C; Borghi MO; Fineschi S; Meroni PL
Biomed Pharmacother; 2003 Sep; 57(7):282-6. PubMed ID: 14499174
[TBL] [Abstract][Full Text] [Related]
4. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
5. Endothelium as a target for antiphospholipid antibodies.
Riboldi P; Gerosa M; Raschi E; Testoni C; Meroni PL
Immunobiology; 2003; 207(1):29-36. PubMed ID: 12638900
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid syndrome: pathophysiology and clinicobiological aspects].
Ksouri H; Mellouli F; Béjaoui M
Arch Inst Pasteur Tunis; 2008; 85(1-4):91-105. PubMed ID: 19469420
[TBL] [Abstract][Full Text] [Related]
7. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
Xie H; Sheng L; Zhou H; Yan J
Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
[TBL] [Abstract][Full Text] [Related]
8. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
Blank M; Shoenfeld Y
Clin Immunol; 2004 Aug; 112(2):190-9. PubMed ID: 15240163
[TBL] [Abstract][Full Text] [Related]
9. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
Takeda K
J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response and the endothelium.
Meroni PL; Borghi MO; Raschi E; Ventura D; Sarzi Puttini PC; Atzeni F; Lonati L; Parati G; Tincani A; Mari D; Tedesco F
Thromb Res; 2004; 114(5-6):329-34. PubMed ID: 15507262
[TBL] [Abstract][Full Text] [Related]
12. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
13. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
[TBL] [Abstract][Full Text] [Related]
16. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.
Säemann MD; Weichhart T; Zeyda M; Staffler G; Schunn M; Stuhlmeier KM; Sobanov Y; Stulnig TM; Akira S; von Gabain A; von Ahsen U; Hörl WH; Zlabinger GJ
J Clin Invest; 2005 Feb; 115(2):468-75. PubMed ID: 15650774
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.
Borghi MO; Raschi E; Grossi C; Chighizola CB; Meroni PL
Lupus; 2014 Oct; 23(12):1302-4. PubMed ID: 25228733
[TBL] [Abstract][Full Text] [Related]
18. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
19. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors and adaptor molecules in liver disease: update.
Seki E; Brenner DA
Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
